Redfund Capital Corp (CSE: LOAN) (Frankfurt: O3X4) (OTC: PNNRF) (Redfund or the “Company”) is pleased to announce that it has signed a strategic business cooperation agreement with Fantasy Network Ltd. (TASE: FNTS) of Tel Aviv, Israel to joint venture medical cannabis projects.
Redfund Capital and Fantasy Network have entered into a strategic cooperation agreement to form the foundation to joint venture business opportunities in the Israeli medical cannabis sector. This agreement enables Redfund to have a partner in Israel to evaluate potential acquisition and financing of Medical Cannabis, CBD, and Hemp companies in the region. The signed agreement provides a framework for Redfund to be able to access projects currently controlled by Fantasy or under negotiation primarily in Israel. Redfund will also assist Fantasy to license patented Israeli medical technology and cannabis delivery systems outside of Israel, as well as provide capital alongside Fantasy to medical cannabis companies. The term of this agreement is for 3 years.
On June 5, 2019, Fantasy Network announced the appointment of Redfund Capital CEO Meris Kott as an investment advisor to their company. Ms. Kott recently met with management in Tel Aviv and reviewed Fantasy’s current medical Cannabis portfolio with the aim to begin immediately.
Globally known as the best in class, Israel has a plethora of cannabis researchers, farmers, and entrepreneurs all focused on medical cannabis. The Israeli government has given support to the industry since 1973 and with recent approval from the Israeli parliament to export Israeli products, the global market is now open for Israeli companies to expand worldwide.
“Israel is home to novel cannabis drug delivery devices, patented grow and planting technologies, holistic cannaceuticals and pharma-grade medical cannabis. The people and companies I was introduced to during my trip to Tel Aviv, assures me that Redfund’s partnership with Fantasy will be a lucrative relationship for both our stakeholders. Redfund is already in discussions to bring Israel medical cannabis based companies global with Israeli licensing agreements with Canadian Licenced Producers and distribution contracts in other countries where medical cannabis is legalized,” stated Meris Kott, CEO.
About Redfund Capital
Redfund intends to provide debt and equity funding in the mid-to-late stages of a target company’s development, or in technologies that are developed and validated by revenues. The present focus of the merchant bank is on medical cannabis, hemp and CBD-related, healthcare-related target companies.
For further information please visit www.redfundcapital.com
For more information on Redfund Capital contact
Meris Kott CEO 604.484.8989
Further information about the Company is available on www.SEDAR.com under the Company’s profile.
Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release. Certain statements contained in this release may constitute “forward-looking statements” or “forward-looking information” (collectively “forward-looking information”) as those terms are used in the Private Securities Litigation Reform Act of 1995 and similar Canadian laws. These statements relate to future events or future performance. The use of any of the words “could”, “intend”, “expect”, “believe”, “will”, “projected”, “estimated”, “anticipates” and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the Company’s current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. In particular, this release contains forward-looking information relating to the business of the Company, the Property, financing and certain corporate changes. The forward-looking information contained in this release is made as of the date hereof and the Company is not obligated to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on forward-looking information. The foregoing statements expressly qualify any forward-looking information contained herein.